We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$273M
Cap. Flow %
1.9%
Top 10 Hldgs %
37.21%
Holding
1,342
New
30
Increased
738
Reduced
241
Closed
27

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$79.2M
2
DLR icon
Digital Realty Trust
DLR
+$75.4M
3
SPG icon
Simon Property Group
SPG
+$73M
4
INVH icon
Invitation Homes
INVH
+$60.9M
5
REXR icon
Rexford Industrial Realty
REXR
+$44.2M

Top Sells

Rank Stock Value
1
LAMR icon
Lamar Advertising Co
LAMR
+$81.1M
2
PSA icon
Public Storage
PSA
+$63.6M
3
DOC icon
Healthpeak Properties
DOC
+$53.3M
4
SUI icon
Sun Communities
SUI
+$47.6M
5
KIM icon
Kimco Realty
KIM
+$34.4M

Sector Composition

Rank Sector Weight
1 Real Estate 55.05%
2 Technology 11.48%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1126
DELISTED
Arcellx
ACLX
$5K ﹤0.01%
176
– –
ADPT icon
1127
Adaptive Biotechnologies
ADPT
$3.61B
$5K ﹤0.01%
530
– –
AGIO icon
1128
Agios Pharmaceuticals
AGIO
$2.08B
$5K ﹤0.01%
204
– –
ARVN icon
1129
Arvinas
ARVN
$530M
$5K ﹤0.01%
198
– –
DBC icon
1130
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$5K ﹤0.01%
200
– –
IMCR icon
1131
Immunocore
IMCR
$1.7B
$5K ﹤0.01%
104
– –
IOVA icon
1132
Iovance Biotherapeutics
IOVA
$2.04B
$5K ﹤0.01%
877
+291
+50% +$2.01K
KROS icon
1133
Keros Therapeutics
KROS
$197M
$5K ﹤0.01%
111
– –
LGND icon
1134
Ligand Pharmaceuticals
LGND
$5.77B
$5K ﹤0.01%
63
– –
NUVL
1135
DELISTED
Nuvalent
NUVL
$5K ﹤0.01%
205
– –
PLRX icon
1136
Pliant Therapeutics
PLRX
$65M
$5K ﹤0.01%
196
– –
RCKT icon
1137
Rocket Pharmaceuticals
RCKT
$343M
$5K ﹤0.01%
304
– –
SMMT icon
1138
Summit Therapeutics
SMMT
$10.2B
$5K ﹤0.01%
2,728
+1,918
+237% +$5.23K
SNDX icon
1139
Syndax Pharmaceuticals
SNDX
$1.7B
$5K ﹤0.01%
242
– –
VRNA
1140
DELISTED
Verona Pharma
VRNA
$5K ﹤0.01%
244
– –
KDNY
1141
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$5K ﹤0.01%
230
– –
ARDX icon
1142
Ardelyx
ARDX
$1.24B
$4K ﹤0.01%
754
– –
DAWN
1143
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
296
– –
MIRM icon
1144
Mirum Pharmaceuticals
MIRM
$6.56B
$4K ﹤0.01%
148
– –
MNKD icon
1145
MannKind Corp
MNKD
$1.19B
$4K ﹤0.01%
1,058
– –
PTGX icon
1146
Protagonist Therapeutics
PTGX
$8.55B
$4K ﹤0.01%
163
– –
REPL icon
1147
Replimune Group
REPL
$454M
$4K ﹤0.01%
200
– –
RYTM icon
1148
Rhythm Pharmaceuticals
RYTM
$7.31B
$4K ﹤0.01%
227
– –
ZNTL icon
1149
Zentalis Pharmaceuticals
ZNTL
$332M
$4K ﹤0.01%
212
– –
DCPH
1150
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
272
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daiwa Securities Group held 1,342 positions worth $14.4B, up 10% from $13B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Daiwa Securities Group opened 30 new positions and exited 27, leaving the 1,342-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2023 buy was Global X Aging Population ETF: 800,000 shares worth $21.4M.
  • Daiwa Securities Group added most to VICI Properties in Q1 2023, an estimated $79.2M increase.
  • Daiwa Securities Group's biggest Q1 2023 reduction was Lamar Advertising Co, cutting an estimated $81.1M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $15.2M.
  • Daiwa Securities Group's ten largest holdings make up 37% of its $14.4B portfolio in Q1 2023.
  • Daiwa Securities Group opened 30 new positions and closed 27 in Q1 2023.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.